Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 168

1.

Assessment of renal deterioration and associated risk factors in patients with multiple sclerosis.

Shakir NA, Satyanarayan A, Eastman J, Greenberg BM, Lemack GE.

Urology. 2018 Sep 26. pii: S0090-4295(18)31000-8. doi: 10.1016/j.urology.2018.09.014. [Epub ahead of print]

PMID:
30267726
2.

Area postrema syndrome: Frequency, criteria, and severity in AQP4-IgG-positive NMOSD.

Shosha E, Dubey D, Palace J, Nakashima I, Jacob A, Fujihara K, Takahashi T, Whittam D, Leite MI, Misu T, Yoshiki T, Messina S, Elsone L, Majed M, Flanagan E, Gadoth A, Huebert C, Sagen J, Greenberg BM, Levy M, Banerjee A, Weinshenker B, Pittock SJ.

Neurology. 2018 Sep 26. pii: 10.1212/WNL.0000000000006392. doi: 10.1212/WNL.0000000000006392. [Epub ahead of print]

PMID:
30258024
3.

Safety and efficacy of plasma exchange in pediatric transverse myelitis.

Noland DK, Greenberg BM.

Neurol Clin Pract. 2018 Aug;8(4):327-330. doi: 10.1212/CPJ.0000000000000480.

PMID:
30140584
4.

BRAF mutation leading to central nervous system rosai-dorfman disease.

Richardson TE, Wachsmann M, Oliver D, Abedin Z, Ye D, Burns DK, Raisanen JM, Greenberg BM, Hatanpaa KJ.

Ann Neurol. 2018 Jul;84(1):147-152. doi: 10.1002/ana.25281. Epub 2018 Aug 16.

PMID:
30014527
5.

A whole-genome sequence study identifies genetic risk factors for neuromyelitis optica.

Estrada K, Whelan CW, Zhao F, Bronson P, Handsaker RE, Sun C, Carulli JP, Harris T, Ransohoff RM, McCarroll SA, Day-Williams AG, Greenberg BM, MacArthur DG.

Nat Commun. 2018 May 16;9(1):1929. doi: 10.1038/s41467-018-04332-3.

6.

A double-blind, placebo-controlled, single ascending-dose study of remyelinating antibody rHIgM22 in people with multiple sclerosis.

Eisen A, Greenberg BM, Bowen JD, Arnold DL, Caggiano AO.

Mult Scler J Exp Transl Clin. 2017 Nov 21;3(4):2055217317743097. doi: 10.1177/2055217317743097. eCollection 2017 Oct-Dec.

7.

Pediatric Multiple Sclerosis: From Recognition to Practical Clinical Management.

Wang CX, Greenberg BM.

Neurol Clin. 2018 Feb;36(1):135-149. doi: 10.1016/j.ncl.2017.08.005. Review.

PMID:
29157395
8.

A Callosal Catastrophe: Toxic Leukoencephalopathy Associated with Thermogenic Weight Loss Supplement Use.

Mahdavi ZK, Narayan R, Mainali S, Greenberg BM, Aiyagari V, McDonagh DL.

Neurocrit Care. 2017 Oct 18. doi: 10.1007/s12028-017-0473-9. [Epub ahead of print]

PMID:
29047014
9.

Myelin oligodendrocyte glycoprotein-specific antibodies from multiple sclerosis patients exacerbate disease in a humanized mouse model.

Khare P, Challa DK, Devanaboyina SC, Velmurugan R, Hughes S, Greenberg BM, Ober RJ, Ward ES.

J Autoimmun. 2018 Jan;86:104-115. doi: 10.1016/j.jaut.2017.09.002. Epub 2017 Sep 28.

10.

Statistical classifiers for diagnosing disease from immune repertoires: a case study using multiple sclerosis.

Ostmeyer J, Christley S, Rounds WH, Toby I, Greenberg BM, Monson NL, Cowell LG.

BMC Bioinformatics. 2017 Sep 7;18(1):401. doi: 10.1186/s12859-017-1814-6.

11.

Aquaporin-4 serostatus does not predict response to immunotherapy in neuromyelitis optica spectrum disorders.

Mealy MA, Kim SH, Schmidt F, López R, Jimenez Arango JA, Paul F, Wingerchuk DM, Greenberg BM, Kim HJ, Levy M.

Mult Scler. 2017 Aug 1:1352458517730131. doi: 10.1177/1352458517730131. [Epub ahead of print]

PMID:
28857723
12.

Development of Glatopa® (Glatiramer Acetate): The First FDA-Approved Generic Disease-Modifying Therapy for Relapsing Forms of Multiple Sclerosis.

Bell C, Anderson J, Ganguly T, Prescott J, Capila I, Lansing JC, Sachleben R, Iyer M, Fier I, Roach J, Storey K, Miller P, Hall S, Kantor D, Greenberg BM, Nair K, Glajch J.

J Pharm Pract. 2018 Oct;31(5):481-488. doi: 10.1177/0897190017725984. Epub 2017 Aug 29.

13.

Neuropsychological outcomes of pediatric demyelinating diseases: a review.

Tan A, Hague C, Greenberg BM, Harder L.

Child Neuropsychol. 2018 Jul;24(5):575-597. doi: 10.1080/09297049.2017.1339785. Epub 2017 Jun 21.

PMID:
28637379
14.

Dietary factors and pediatric multiple sclerosis: A case-control study.

Pakpoor J, Seminatore B, Graves JS, Schreiner T, Waldman AT, Lotze TE, Belman A, Greenberg BM, Weinstock-Guttman B, Aaen G, Tillema JM, McDonald JC, Hart J, Ness JM, Harris Y, Rubin J, Candee M, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Mar S, Kahn I, Rose J, Carmichael SL, Roalstad S, Waltz M, Casper TC, Waubant E; US Network of Pediatric Multiple Sclerosis Centers.

Mult Scler. 2018 Jul;24(8):1067-1076. doi: 10.1177/1352458517713343. Epub 2017 Jun 13.

PMID:
28608728
15.

Opinion: Taking phytoremediation from proven technology to accepted practice.

Gerhardt KE, Gerwing PD, Greenberg BM.

Plant Sci. 2017 Mar;256:170-185. doi: 10.1016/j.plantsci.2016.11.016. Epub 2016 Dec 5. Review.

PMID:
28167031
16.

Peripheral VH4+ plasmablasts demonstrate autoreactive B cell expansion toward brain antigens in early multiple sclerosis patients.

Rivas JR, Ireland SJ, Chkheidze R, Rounds WH, Lim J, Johnson J, Ramirez DM, Ligocki AJ, Chen D, Guzman AA, Woodhall M, Wilson PC, Meffre E, White C 3rd, Greenberg BM, Waters P, Cowell LG, Stowe AM, Monson NL.

Acta Neuropathol. 2017 Jan;133(1):43-60. doi: 10.1007/s00401-016-1627-0. Epub 2016 Oct 11.

17.

Pediatric transverse myelitis.

Absoud M, Greenberg BM, Lim M, Lotze T, Thomas T, Deiva K.

Neurology. 2016 Aug 30;87(9 Suppl 2):S46-52. doi: 10.1212/WNL.0000000000002820. Review.

PMID:
27572861
18.

Induction of regulatory T-cells from memory T-cells is perturbed during acute exacerbation of multiple sclerosis.

Mohiuddin IH, Pillai V, Baughman EJ, Greenberg BM, Frohman EM, Crawford MP, Sinha S, Karandikar NJ.

Clin Immunol. 2016 May;166-167:12-8. doi: 10.1016/j.clim.2016.05.001. Epub 2016 May 3.

19.

A Single Amino Acid Substitution Prevents Recognition of a Dominant Human Aquaporin-4 Determinant in the Context of HLA-DRB1*03:01 by a Murine TCR.

Arellano B, Hussain R, Miller-Little WA, Herndon E, Lambracht-Washington D, Eagar TN, Lewis R, Healey D, Vernino S, Greenberg BM, Stüve O.

PLoS One. 2016 Apr 7;11(4):e0152720. doi: 10.1371/journal.pone.0152720. eCollection 2016.

20.

Vitamin D During Pregnancy and Multiple Sclerosis: An Evolving Association.

Greenberg BM.

JAMA Neurol. 2016 May 1;73(5):498-9. doi: 10.1001/jamaneurol.2016.0018. No abstract available.

PMID:
26953523
21.

Does Autoimmunity have a Role in Myoclonic Astatic Epilepsy? A Case Report of Voltage Gated Potassium Channel Mediated Seizures.

Sirsi D, Dolce A, Greenberg BM, Thodeson D.

Ann Clin Case Rep. 2016;1. pii: 1178. Epub 2016 Nov 3.

22.

Urodynamics findings in transverse myelitis patients with lower urinary tract symptoms: Results from a tertiary referral urodynamic center.

Gliga LA, Lavelle RS, Christie AL, Coskun B, Greenberg BM, Carmel ME, Lemack GE.

Neurourol Urodyn. 2017 Feb;36(2):360-363. doi: 10.1002/nau.22930. Epub 2015 Nov 20.

PMID:
26587780
23.

A Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis Patients.

Ligocki AJ, Rivas JR, Rounds WH, Guzman AA, Li M, Spadaro M, Lahey L, Chen D, Henson PM, Graves D, Greenberg BM, Frohman EM, Ward ES, Robinson W, Meinl E, White CL 3rd, Stowe AM, Monson NL.

ASN Neuro. 2015 Oct 21;7(5). pii: 1759091415609613. doi: 10.1177/1759091415609613. Print 2015 Sep-Oct.

24.

Equivalent Gene Expression Profiles between Glatopa™ and Copaxone®.

D'Alessandro JS, Duffner J, Pradines J, Capila I, Garofalo K, Kaundinya G, Greenberg BM, Kantor D, Ganguly TC.

PLoS One. 2015 Oct 16;10(10):e0140299. doi: 10.1371/journal.pone.0140299. eCollection 2015.

25.

Neuromyelitis Optica Spectrum Disorder Associated With Autoimmune Hemolytic Anemia and Lymphoma.

Wang Y, Miocinovic S, Greenberg BM.

Neurologist. 2015 Aug;20(2):33-4. doi: 10.1097/NRL.0000000000000043.

PMID:
26280288
26.

MSPrecise: A molecular diagnostic test for multiple sclerosis using next generation sequencing.

Rounds WH, Salinas EA, Wilks TB 2nd, Levin MK, Ligocki AJ, Ionete C, Pardo CA, Vernino S, Greenberg BM, Bigwood DW, Eastman EM, Cowell LG, Monson NL.

Gene. 2015 Nov 10;572(2):191-7. doi: 10.1016/j.gene.2015.07.011. Epub 2015 Jul 11.

27.

Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder.

Kremer S, Renard F, Achard S, Lana-Peixoto MA, Palace J, Asgari N, Klawiter EC, Tenembaum SN, Banwell B, Greenberg BM, Bennett JL, Levy M, Villoslada P, Saiz A, Fujihara K, Chan KH, Schippling S, Paul F, Kim HJ, de Seze J, Wuerfel JT; Guthy-Jackson Charitable Foundation (GJCF) Neuromyelitis Optica (NMO) International Clinical Consortium and Biorepository, Cabre P, Marignier R, Tedder T, van Pelt D, Broadley S, Chitnis T, Wingerchuk D, Pandit L, Leite MI, Apiwattanakul M, Kleiter I, Prayoonwiwat N, Han M, Hellwig K, van Herle K, John G, Hooper DC, Nakashima I, Sato D, Yeaman MR, Waubant E, Zamvil S, Stüve O, Aktas O, Smith TJ, Jacob A, O'Connor K.

JAMA Neurol. 2015 Jul;72(7):815-22. doi: 10.1001/jamaneurol.2015.0248. Review.

28.

Placebo studies should not be undertaken in NMO--No.

Greenberg BM.

Mult Scler. 2015 May;21(6):691-3. doi: 10.1177/1352458515579217. Epub 2015 Apr 28. No abstract available.

PMID:
25921044
29.

Intravenous methylprednisolone versus therapeutic plasma exchange for treatment of anti-N-methyl-D-aspartate receptor antibody encephalitis: A retrospective review.

DeSena AD, Noland DK, Matevosyan K, King K, Phillips L, Qureshi SS, Greenberg BM, Graves D.

J Clin Apher. 2015 Aug;30(4):212-6. doi: 10.1002/jca.21363. Epub 2015 Feb 9.

PMID:
25664728
30.

Immune-mediated myelopathies.

Greenberg BM, Frohman EM.

Continuum (Minneap Minn). 2015 Feb;21(1 Spinal Cord Disorders):121-31. doi: 10.1212/01.CON.0000461088.63994.a2.

PMID:
25651221
31.

Peripheral nerve involvement in adult and pediatric patients with central nervous system inflammatory disease--reply.

Greenberg BM.

JAMA Neurol. 2015 Jan;72(1):123-4. doi: 10.1001/jamaneurol.2014.3527. No abstract available.

PMID:
25581861
32.

The antibody genetics of multiple sclerosis: comparing next-generation sequencing to sanger sequencing.

Rounds WH, Ligocki AJ, Levin MK, Greenberg BM, Bigwood DW, Eastman EM, Cowell LG, Monson NL.

Front Neurol. 2014 Sep 16;5:166. doi: 10.3389/fneur.2014.00166. eCollection 2014.

33.

Three phenotypes of anti-N-methyl-D-aspartate receptor antibody encephalitis in children: prevalence of symptoms and prognosis.

DeSena AD, Greenberg BM, Graves D.

Pediatr Neurol. 2014 Oct;51(4):542-9. doi: 10.1016/j.pediatrneurol.2014.04.030. Epub 2014 May 29. Review.

PMID:
25070939
34.

"Light switch" mental status changes and irritable insomnia are two particularly salient features of anti-NMDA receptor antibody encephalitis.

DeSena AD, Greenberg BM, Graves D.

Pediatr Neurol. 2014 Jul;51(1):151-3. doi: 10.1016/j.pediatrneurol.2013.09.012. Epub 2013 Sep 27.

PMID:
24938143
35.

Plant growth-promoting bacteria facilitate the growth of barley and oats in salt-impacted soil: implications for phytoremediation of saline soils.

Chang P, Gerhardt KE, Huang XD, Yu XM, Glick BR, Gerwing PD, Greenberg BM.

Int J Phytoremediation. 2014;16(7-12):1133-47.

PMID:
24933907
36.

Monocular and binocular low-contrast visual acuity and optical coherence tomography in pediatric multiple sclerosis.

Waldman AT, Hiremath G, Avery RA, Conger A, Pineles SL, Loguidice MJ, Talman LS, Galetta KM, Shumski MJ, Wilson J, Ford E, Lavery AM, Conger D, Greenberg BM, Ellenberg JH, Frohman EM, Balcer LJ, Calabresi PA.

Mult Scler Relat Disord. 2013 May 1;3(3):326-334.

37.

Proteoform analysis of lipocalin-type prostaglandin D-synthase from human cerebrospinal fluid by isoelectric focusing and superficially porous liquid chromatography with Fourier transform mass spectrometry.

Zhang J, Corbett JR, Plymire DA, Greenberg BM, Patrie SM.

Proteomics. 2014 May;14(10):1223-31. doi: 10.1002/pmic.201300368. Epub 2014 Mar 20.

PMID:
24678018
38.

Disease exacerbation of multiple sclerosis is characterized by loss of terminally differentiated autoregulatory CD8+ T cells.

Cunnusamy K, Baughman EJ, Franco J, Ortega SB, Sinha S, Chaudhary P, Greenberg BM, Frohman EM, Karandikar NJ.

Clin Immunol. 2014 May-Jun;152(1-2):115-26. doi: 10.1016/j.clim.2014.03.005. Epub 2014 Mar 20.

39.

Transverse myelitis plus syndrome and acute disseminated encephalomyelitis plus syndrome: a case series of 5 children.

DeSena A, Graves D, Morriss MC, Greenberg BM.

JAMA Neurol. 2014 May;71(5):624-9. doi: 10.1001/jamaneurol.2013.5323. Review.

PMID:
24637847
40.

Herpes simplex encephalitis as a potential cause of anti-N-methyl-D-aspartate receptor antibody encephalitis: report of 2 cases.

Desena A, Graves D, Warnack W, Greenberg BM.

JAMA Neurol. 2014 Mar;71(3):344-6. doi: 10.1001/jamaneurol.2013.4580.

PMID:
24473671
41.

Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy.

Mealy MA, Wingerchuk DM, Palace J, Greenberg BM, Levy M.

JAMA Neurol. 2014 Mar;71(3):324-30. doi: 10.1001/jamaneurol.2013.5699.

PMID:
24445513
42.

Elevated CNS inflammation in patients with preclinical Alzheimer's disease.

Monson NL, Ireland SJ, Ligocki AJ, Chen D, Rounds WH, Li M, Huebinger RM, Munro Cullum C, Greenberg BM, Stowe AM, Zhang R.

J Cereb Blood Flow Metab. 2014 Jan;34(1):30-3. doi: 10.1038/jcbfm.2013.183. Epub 2013 Oct 23.

43.

Requirement for safety monitoring for approved multiple sclerosis therapies: an overview.

Rommer PS, Zettl UK, Kieseier B, Hartung HP, Menge T, Frohman E, Greenberg BM, Hemmer B, Stüve O.

Clin Exp Immunol. 2014 Mar;175(3):397-407. doi: 10.1111/cei.12206. Review.

44.

Top-down mass spectrometry on tissue extracts and biofluids with isoelectric focusing and superficially porous silica liquid chromatography.

Zhang J, Roth MJ, Chang AN, Plymire DA, Corbett JR, Greenberg BM, Patrie SM.

Anal Chem. 2013 Nov 5;85(21):10377-84. doi: 10.1021/ac402394w. Epub 2013 Oct 16.

PMID:
24074297
45.

Uhthoff's phenomena in MS--clinical features and pathophysiology.

Frohman TC, Davis SL, Beh S, Greenberg BM, Remington G, Frohman EM.

Nat Rev Neurol. 2013 Sep;9(9):535-40. doi: 10.1038/nrneurol.2013.98. Epub 2013 Jun 4. Review.

PMID:
23732530
46.

Blind and confused.

Sharma VD, Malafronte P, De Simone N, Greenberg BM.

JAMA Neurol. 2013 Jul;70(7):932-6. doi: 10.1001/jamaneurol.2013.3105.

PMID:
23712605
47.

Interferon beta and long-term disability in multiple sclerosis--reply.

Greenberg BM, Frohman E.

JAMA Neurol. 2013 May;70(5):652-3. doi: 10.1001/jamaneurol.2013.1. No abstract available.

PMID:
23699949
48.

Modulation of immune function occurs within hours of therapy initiation for multiple sclerosis.

Ayers CL, Mendoza JP, Sinha S, Cunnusamy K, Greenberg BM, Frohman EM, Karandikar NJ.

Clin Immunol. 2013 May;147(2):105-19. doi: 10.1016/j.clim.2013.02.015. Epub 2013 Mar 6.

49.

Interferon beta use and disability prevention in relapsing-remitting multiple sclerosis.

Greenberg BM, Balcer L, Calabresi PA, Cree B, Cross A, Frohman T, Gold R, Havrdova E, Hemmer B, Kieseier BC, Lisak R, Miller A, Racke MK, Steinman L, Stuve O, Wiendl H, Frohman E.

JAMA Neurol. 2013 Feb;70(2):248-51. No abstract available.

PMID:
23530268
50.

What is the true clinicopathologic spectrum of neuromyelitis optica?-Reply.

Greenberg BM, Wingerchuk D, Mealy M, Levy M.

JAMA Neurol. 2013 Feb;70(2):272-3. doi: 10.1001/jamaneurol.2013.1286. No abstract available.

PMID:
23400728

Supplemental Content

Loading ...
Support Center